• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Production and characterization of recombinant human plasminogen(S741C-fluorescein). A novel approach to study zymogen activation without generation of active protease.

作者信息

Horrevoets A J, Pannekoek H, Nesheim M E

机构信息

Departments of Biochemistry and Medicine, Queen's University, Kingston, Ontario, Canada, K7L 3N6.

出版信息

J Biol Chem. 1997 Jan 24;272(4):2176-82. doi: 10.1074/jbc.272.4.2176.

DOI:10.1074/jbc.272.4.2176
PMID:8999920
Abstract

A variant of recombinant plasminogen with the plasmin active site serine (S741) replaced by cysteine was produced and labeled with fluorescein at this residue to provide the derivative Plg(S741C-fluorescein). Studies of cleavage, conformation, and fibrin-binding properties of the derivative showed it to be a good model substrate to study plasminogen activation. Both in solution and in a fully polymerized fibrin clot, cleavage of the single chain zymogen to the two-chain "plasmin" molecule was accompanied by a 50% quench of fluorescence intensity. This change allows facile, continuous monitoring of the kinetics of cleavage. Measurements of cleavage by single chain t-PA within intact, fully polymerized 3 microM fibrin yielded apparent kcat and Km values of (0.08 s-1, 0.52 microM) and (0.092 s-1, 0.098 microM) for [Glu1]- and [Lys78]Plg(S741C-fluorescein), respectively. These values are similar to those obtained by others with plasma plasminogen. The approach used here might generally be useful in simplifying the analysis of zymogen activation kinetics in cases where the product (protease) has a great influence on its own formation via positive or negative feedback loops.

摘要

相似文献

1
Production and characterization of recombinant human plasminogen(S741C-fluorescein). A novel approach to study zymogen activation without generation of active protease.
J Biol Chem. 1997 Jan 24;272(4):2176-82. doi: 10.1074/jbc.272.4.2176.
2
A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain.一种稳态模板模型,该模型描述了天然组织型纤溶酶原激活剂以及缺乏指状结构域或kringle-2结构域的变体对纤维蛋白刺激的[Glu1]-和[Lys78]纤溶酶原激活的动力学。
J Biol Chem. 1997 Jan 24;272(4):2183-91. doi: 10.1074/jbc.272.4.2183.
3
Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.通过对赖氨酸158、异亮氨酸159和异亮氨酸160进行位点特异性诱变获得的重组单链尿激酶型纤溶酶原激活剂突变体的结构和功能表征。
Eur J Biochem. 1988 Nov 15;177(3):575-82. doi: 10.1111/j.1432-1033.1988.tb14409.x.
4
Variants of tissue-type plasminogen activator which display substantially enhanced stimulation by fibrin.
J Biol Chem. 1995 Aug 4;270(31):18319-22. doi: 10.1074/jbc.270.31.18319.
5
Reexamination of the extent of the activation of Lys78 plasminogen by tissue plasminogen activator in the presence of polymerized fibrin.在存在聚合纤维蛋白的情况下,重新检查组织型纤溶酶原激活物对赖氨酸78纤溶酶原的激活程度。
Haemostasis. 1996 Jul-Aug;26(4):220-7. doi: 10.1159/000217211.
6
Characterization of a chimaeric plasminogen activator obtained by insertion of the second kringle structure of tissue-type plasminogen activator (amino acids 173 through 262) between residues Asp130 and Ser139 of urokinase-type plasminogen activator.
Thromb Res. 1988 Dec 1;52(5):431-41. doi: 10.1016/0049-3848(88)90027-8.
7
Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.由纤维蛋白特异性抗体的单链Fv片段和单链尿激酶组成的单链嵌合纤溶酶原激活剂的生化特性
Eur J Biochem. 1992 Dec 15;210(3):945-52. doi: 10.1111/j.1432-1033.1992.tb17499.x.
8
An active zymogen: unravelling the mystery of tissue-type plasminogen activator.一种活性酶原:揭开组织型纤溶酶原激活剂的奥秘
Biol Chem. 1998 Feb;379(2):95-103. doi: 10.1515/bchm.1998.379.2.95.
9
Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.组织型纤溶酶原激活剂与尿激酶型纤溶酶原激活剂杂交体中的结构域间相互作用
Protein Eng. 1995 Dec;8(12):1295-1302. doi: 10.1093/protein/8.12.1295.
10
Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study.
J Biol Chem. 1987 Nov 5;262(31):14998-5003.

引用本文的文献

1
The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.膜联蛋白 A2/钙结合蛋白 S100A10 复合物对致癌性纤溶酶原受体的调控作用。
Biomolecules. 2021 Nov 26;11(12):1772. doi: 10.3390/biom11121772.
2
Activated thrombin-activatable fibrinolysis inhibitor (TAFIa) attenuates fibrin-dependent plasmin generation on thrombin-activated platelets.激活的凝血酶激活的纤溶抑制物(TAFIa)可减弱在凝血酶激活的血小板上纤维蛋白依赖性纤溶酶原的生成。
J Thromb Haemost. 2020 Sep;18(9):2364-2376. doi: 10.1111/jth.14950.
3
Reduced plasminogen binding and delayed activation render γ'-fibrin more resistant to lysis than γA-fibrin.
纤溶酶原结合减少和激活延迟使γ'-纤维蛋白比γA-纤维蛋白对溶解更具抗性。
J Biol Chem. 2014 Oct 3;289(40):27494-503. doi: 10.1074/jbc.M114.588640. Epub 2014 Aug 15.
4
Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.凝血酶激活的纤溶抑制物激活与血友病 A 的出血。
Haemophilia. 2012 May;18(3):e316-22. doi: 10.1111/j.1365-2516.2011.02648.x. Epub 2011 Sep 20.
5
Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites.活化凝血酶激活纤溶抑制物(TAFIa)催化纤维蛋白降解产物 C 末端赖氨酸残基裂解及去除纤溶酶原结合位点的动力学。
J Biol Chem. 2011 Jun 3;286(22):19280-6. doi: 10.1074/jbc.M110.215061. Epub 2011 Apr 5.
6
The generation and characterization of mice expressing a plasmin-inactivating active site mutation.表达纤溶酶失活活性位点突变的小鼠的产生与表征
J Thromb Haemost. 2010 Oct;8(10):2341-4. doi: 10.1111/j.1538-7836.2010.03995.x.
7
Thrombin-activable fibrinolysis inhibitor zymogen does not play a significant role in the attenuation of fibrinolysis.凝血酶可激活的纤维蛋白溶解抑制剂酶原在纤维蛋白溶解的减弱过程中不起重要作用。
J Biol Chem. 2008 Apr 4;283(14):8863-7. doi: 10.1074/jbc.M800127200. Epub 2008 Feb 5.